Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Dupont

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Annals of Clinical and Laboratory Science|June 24, 2021
Lymphocytic Esophagitis Is Not Similar to Eosinophilic Esophagitis Except for Seasonal VariationMeera Avila, Manju Ambelil, Yi Tong, et al.
Digestion|November 14, 1998
Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers' diarrheaH L DuPont, C D Ericsson, J J Mathewson, et al.
Chronobiologia|January 1, 1981
Clinical chronopharmacology of ACTH 1-17. II. Effects on plasma testosterone, plasma aldosterone, plasma and urinary electrolytes (K, Na, Ca and Mg)A Reinberg, W Dupont, Y Touitou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2005
Antibacterial chemoprophylaxis in the prevention of traveler's diarrhea: evaluation of poorly absorbed oral rifaximinHerbert L DuPont, Zhi-Dong Jiang, Pablo C Okhuysen, et al.
Annals of Internal Medicine|May 18, 2005
A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrheaHerbert L DuPont, Zhi-Dong Jiang, Pablo C Okhuysen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2001
Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trialH L DuPont, Z D Jiang, C D Ericsson, et al.
Frontiers in Neurology|March 20, 2023
Fecal microbiota transplantation in Parkinson's disease-A randomized repeat-dose, placebo-controlled clinical pilot studyHerbert L DuPont, Jessika Suescun, Zhi-Dong Jiang, et al.
The American Journal of Tropical Medicine and Hygiene|April 7, 2009
Coliform and Escherichia coli contamination of desserts served in public restaurants from Guadalajara, Mexico, and Houston, TexasKaren J Vigil, Zhi-Dong Jiang, Jaclyn J Chen, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2017
Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection - fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopyZ D Jiang, N J Ajami, J F Petrosino, et al.
Plos One|November 3, 2018
Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: A randomized clinical trialZhi-Dong Jiang, Robert R Jenq, Nadim J Ajami, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Annals of Clinical and Laboratory Science|June 24, 2021
Lymphocytic Esophagitis Is Not Similar to Eosinophilic Esophagitis Except for Seasonal VariationMeera Avila, Manju Ambelil, Yi Tong, et al.
Digestion|November 14, 1998
Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers' diarrheaH L DuPont, C D Ericsson, J J Mathewson, et al.
Chronobiologia|January 1, 1981
Clinical chronopharmacology of ACTH 1-17. II. Effects on plasma testosterone, plasma aldosterone, plasma and urinary electrolytes (K, Na, Ca and Mg)A Reinberg, W Dupont, Y Touitou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2005
Antibacterial chemoprophylaxis in the prevention of traveler's diarrhea: evaluation of poorly absorbed oral rifaximinHerbert L DuPont, Zhi-Dong Jiang, Pablo C Okhuysen, et al.
Annals of Internal Medicine|May 18, 2005
A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrheaHerbert L DuPont, Zhi-Dong Jiang, Pablo C Okhuysen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2001
Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trialH L DuPont, Z D Jiang, C D Ericsson, et al.
Frontiers in Neurology|March 20, 2023
Fecal microbiota transplantation in Parkinson's disease-A randomized repeat-dose, placebo-controlled clinical pilot studyHerbert L DuPont, Jessika Suescun, Zhi-Dong Jiang, et al.
The American Journal of Tropical Medicine and Hygiene|April 7, 2009
Coliform and Escherichia coli contamination of desserts served in public restaurants from Guadalajara, Mexico, and Houston, TexasKaren J Vigil, Zhi-Dong Jiang, Jaclyn J Chen, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2017
Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection - fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopyZ D Jiang, N J Ajami, J F Petrosino, et al.
Plos One|November 3, 2018
Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: A randomized clinical trialZhi-Dong Jiang, Robert R Jenq, Nadim J Ajami, et al.
Pageof 10